Agitation (dementia)

Lore & Background

Agitation in predementia and dementia involves distress, fear, and aggression, which may occur even without repetitive purposeless movements such as pacing. Some authorities consider agitation synonymous with psychomotor agitation, viewing them as a single spectrum where maladaptive movements may appear or recede at various times. Others distinguish them, noting that psychomotor agitation by definition involves maladaptive movements, while agitation in dementia often includes distress and aggression without such movements.

Reader's Guide

Agitation in dementia is a significant clinical challenge, affecting a majority of those with Alzheimer's disease. Evaluation requires ruling out infection, disease, or other bodily discomfort before intervention. If no environmental cause is found, caregiver support and education on strategies like distraction may delay institutional care, which is often triggered by agitation onset. Medical treatment may begin with a cholinesterase inhibitor, which appears safer than alternatives despite mixed evidence for efficacy. If ineffective, atypical antipsychotics offer short-term relief but carry a documented risk of stroke. On May 11, 2023, the FDA approved brexpiprazole (Rexulti) for this condition. Traditional antipsychotics and antidepressants remain less studied.

Did You Know?

• More than 80% of people with Alzheimer's disease eventually become agitated or aggressive.
• Agitation in dementia can involve distress and aggression even when repetitive purposeless movements like pacing are absent.
• On May 11, 2023, the FDA approved brexpiprazole (Rexulti) for treatment of agitation in dementia.
• Atypical antipsychotics are effective against agitation only in the short-term and pose a risk of cerebrovascular events such as stroke.

What Dementia Is and How It Is Classified

Dementia is best understood not as a single illness but as a syndrome—a cluster of progressive cognitive and functional losses that ultimately undermine a person's capacity to carry out ordinary daily tasks. Classified as a major neurocognitive disorder, it typically involves deterioration in memory, reasoning, behavior, and motor coordination, and it is important to distinguish it from the modest cognitive shifts that accompany healthy aging, since intelligence itself does not change. The condition is incurable and progressive, ranging from mild to major severity, and it carries many recognized subtypes. Alzheimer's disease accounts for the largest share, yet dementia can also arise from traumatic brain injury, stroke, Parkinson's disease, Huntington's disease, cerebrovascular disease, HIV infection, frontotemporal lobar degeneration, Lewy body disease, and prion disorders. Some subtypes are further defined by the specific misfolded proteins involved, such as synucleinopathies and tauopathies. When more than one underlying pathology coexists in the same brain, clinicians refer to the condition as mixed dementia.

How Symptoms Manifest Across the Brain

The clinical picture of dementia unfolds across three broad domains—cognitive, neuropsychiatric, and motor—and the particular pattern often hints at the underlying subtype, especially in the early stages. Cognitive deficits typically center on memory plus at least one additional region such as language, attention, problem-solving, or spatial orientation. In practice this shows up as wandering and becoming lost in a well-known neighborhood, reaching for odd words to name familiar objects, forgetting a close family member's name, missing bill payments, or being unable to finish routine tasks without help. Neuropsychiatric features are nearly universal, touching more than ninety percent of cases at some point. Behavioral manifestations include agitation, restlessness, disinhibition, inappropriate conduct, and verbal or physical aggression. Psychological symptoms span depression, hallucinations, delusions, apathy, and anxiety, while personality often shifts toward greater negativity and reduced conscientiousness. Motor signs range from gait changes and repetitive movements to parkinsonism, seizures, and a condition called paratonia in which muscles resist relaxation, sometimes producing fixed postures, skin breakdown, and pain in advanced stages.

Diagnosis and Current Treatment Options

Because dementia is a syndrome rather than a single disease, its diagnosis relies on a combination of the patient's medical history, structured cognitive testing, and neuroimaging. Imaging serves a dual purpose: it helps narrow down which subtype is present and rules out other conditions that might mimic dementia. Blood work is routinely ordered to exclude reversible contributors such as hypothyroidism. For Alzheimer's specifically, fluid biomarkers found in cerebrospinal fluid or peripheral blood can confirm the diagnosis, and positron emission tomography scans can visualize the two hallmark proteins—amyloid beta and tau—that accumulate in the brain. On the treatment side, no cure exists. Acetylcholinesterase inhibitors like donepezil are prescribed for certain subtypes and may offer modest benefit during mild-to-moderate stages, though the overall clinical gain is often small. Cognitive behavioral therapy can help ease the depression that frequently accompanies the condition. Beyond pharmacology, a range of supportive measures aimed at improving quality of life for both the person living with dementia and their caregivers remains the cornerstone of management.

Global Burden and Modifiable Risk

By 2025 dementia has climbed to the seventh leading cause of death worldwide, with roughly ten million new cases emerging each year—equivalent to one new diagnosis about every three seconds. In the United Kingdom the toll is even starker, as dementia tops the list of causes of death. Among people over sixty-five it stands as one of the principal drivers of disability. Age is the single greatest risk factor, yet the condition is emphatically not an inevitable by-product of getting older; many individuals well into their nineties and beyond never develop any signs. Importantly, several risk factors—smoking and obesity among them—are modifiable through lifestyle change, offering a window for prevention. Cultural and socio-environmental contexts shape how risk is assessed, how diagnosis is reached, and how caregiving is organized. The condition's ripple effects extend well beyond the individual, straining family networks, social relationships, and community support systems, which is why public-health attention to both prevention and caregiver support has become increasingly urgent.